Search for: "Abraxis Bioscience, Inc."
Results 1 - 20
of 24
Sort by Relevance
|
Sort by Date
17 Jan 2023, 6:30 am
See Abraxis Bioscience, Inc. v. [read post]
17 Jan 2023, 6:30 am
See Abraxis Bioscience, Inc. v. [read post]
17 Jan 2023, 6:30 am
See Abraxis Bioscience, Inc. v. [read post]
23 Jun 2022, 6:18 am
” Abraxis Bioscience, Inc. v. [read post]
23 Jun 2022, 6:18 am
” Abraxis Bioscience, Inc. v. [read post]
23 Jun 2022, 6:18 am
” Abraxis Bioscience, Inc. v. [read post]
20 Apr 2018, 8:41 am
Cir. 2008); see Abraxis Bioscience, Inc. v.Navinta LLC, 625 F.3d 1359, 1364 (Fed. [read post]
2 Jul 2015, 12:24 pm
Of the matter of employment contracts:Both inventors testified that they transferred theirrights to the inventions they developed to their employerspursuant to their employment contracts. (...)ION argues that there is a defect in thischain of title.It contends that the inventors, while per-haps obligated to transfer rights in the invention to theiremployers (Geco subsidiaries)under their employment agreements, failed to testify that such a transfer in factoccurred.It is well-established that… [read post]
7 Jun 2015, 10:24 pm
June 5, 2015) (quoting Abraxis Bioscience, Inc. v. [read post]
7 Jun 2015, 10:24 pm
June 5, 2015) (quoting Abraxis Bioscience, Inc. v. [read post]
7 Jun 2015, 10:24 pm
June 5, 2015) (quoting Abraxis Bioscience, Inc. v. [read post]
15 Jan 2015, 12:17 pm
Compare,e.g., Abraxis Bioscience, Inc. v. [read post]
19 Feb 2014, 9:59 am
Co., 339 U.S. 605, 609 (1950) (holding that “whether persons reasonably skilled in the art would have known of the interchangeability of an ingredient not contained in the patent with one that was” is an “important factor” weighing in favor of equivalence); Abraxis Bioscience, Inc. v. [read post]
21 Jan 2013, 5:00 am
Patent law seems draconian, as exemplified byAbraxis Bioscience, Inc. v. [read post]
6 Apr 2011, 12:18 am
Laboratorios Rubió (EPLAW) Gemzar (Gemcitabine) – US: ITC: Target date of 23 July 2012 set in Certain Gemcitabine (ITC 337 Law Blog) Intuniv (Guanfacine) – US: Shire files patent infringement complaint based on Mylan’s ANDA filing (Patent Docs) Isentress (Raltegravir) – India: Cipla files for compulsory license against Merck’s Isentress (Spicy IP) Losartan, HCTZ – France: Cour d’appel confirms combination products infringe mono-SPCs and sets… [read post]
19 Mar 2011, 7:02 am
Abraxis BioScience v. [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
12 Nov 2010, 7:06 pm
" Abraxis Bioscience v. [read post]
9 Nov 2010, 10:52 am
See Abraxis Bioscience, 2009 WL 904043, at *1. [read post]
9 Nov 2010, 10:46 am
Abraxis Bioscience Inc. v. [read post]
